UltraGreen.ai is a leading global producer of the Indocyanine Green (“ICG”) surgical dye, which is a near-infrared fluorescent imaging agent administered to aid real-time visualization and intraoperative decisions during surgical procedures. ICG is the most widely used fluorescent agent in Fluorescent Guided Surgeries (“FGS”). UltraGreen.ai operates an AI-based data quantification platform to enhance decision making in FGS and offers a complementary camera system. Incorporated in Singapore, UltraGreen.ai sells its ICG product to over 80 countries worldwide including key markets in the US and Europe.
Who we partnered with
As the anchor investor, 65 Equity Partners will work alongside UltraGreen.ai’s Chief Executive Officer, Ravinder Sajwan, and his senior management team to support UltraGreen.ai in its next phase of growth.
What attracted us to the business
UltraGreen.ai is the global leader in a fast-growing FGS market, with a diverse range of ICG applications unlocking growth opportunities across different medical fields. We are excited to be invested in such a high-quality business with strong fundamentals and look forward to supporting UltraGreen.ai’s continued expansion into new markets and applications.
Website: https://ultragreen.ai/